Literature DB >> 8003117

Reaction of 14C-acetaldehyde with whole blood in vitro: further evidence for the formation of unstable complexes with plasma proteins and red cells.

S N Wickramasinghe1, S Thomas, R Hasan.   

Abstract

When heparinised whole blood was incubated with 5, 10, 45 or 180 microM 14C-acetaldehyde for 1 hr, an average of 33%, 34%, 33% and 41%, respectively, of the radioactivity was associated with red cells and the remainder with plasma. Although 71-80% of the radioactivity in the plasma was TCA-precipitable, only 0.9-3.1% was non-dialysable after 48 hr of dialysis, indicating that much of the acetaldehyde was reversibly bound to protein. When blood was incubated with 10-180 microM 14C-acetaldehyde for 1 hr and the plasma subjected to Sephacryl S300 gel filtration, 0.3-1.9% of the added radioactivity was found in the albumin and IgG fractions; this radioactivity is presumed to reside in both unstable and stable acetaldehyde-protein adducts. Plasma derived from whole blood which was incubated with 5-180 microM acetaldehyde and dialysed for 24 hr displayed cytotoxic activity against A9 cells. These data indicate that when 14C-acetaldehyde is incubated with whole blood, even at concentrations as low as 5-10 microM, a substantial proportion of the radioactive molecules form unstable cytotoxic adducts with plasma proteins and a much smaller proportion form stable adducts. Blood cells (mainly red cells) that were incubated with 14C-acetaldehyde were able to transfer radioactivity to cocultured K562 cells, supporting the possibility that not only acetaldehyde-modified plasma proteins but also acetaldehyde-modified blood cells may transport acetaldehyde and be cytotoxic in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003117

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  3 in total

1.  The effect of acetaldehyde on human plasma factor XIII function.

Authors:  Elizabeth A Suchocki; Arthur S Brecher
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

2.  Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.

Authors:  A S Brecher; K Hellman; M H Basista
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

3.  Coagulation protein function V: diminution of antithrombin III function by acetaldehyde.

Authors:  A S Brecher; K Hellman; C Dulin; M H Basista
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.